are there distinctions among currently available oral egfr inhibitors?
Published 8 years ago • 83 plays • Length 2:22Download video MP4
Download video MP3
Similar videos
-
3:28
are there clinically significant differences among the third generation egfr inhibitors?
-
3:25
are there significant differences among the 1st and 2nd generation egfr tkis?
-
12:58
egfr inhibitor therapy in second line
-
1:01
dr. philip bonomi: gefitinib and later generations of egfr inhibitors
-
3:28
should third generation egfr inhibitors be used before or after progression?
-
1:59
what is egfr and the egfr mutation?
-
2:19
differences among specific egfr mutations
-
2:21
should egfr tki therapy be continued beyond progression?
-
2:08
grace targeted therapies lung cancer 2021 - approved therapy for a cdkn2a secondary mutation?
-
4:44
are there clinically significant differences among the second generation alk inhibitors?
-
26:27
novel egfr inhibitors in the setting of acquired resistance
-
4:31
grace targeted therapies lung cancer 2021 -recommended 2nd line & timing, stage 3 ros-1 lung cancer?
-
4:22
what is egfr in lung cancer? - 2022 program: targeted therapies forum
-
5:06
case based panel discussion - egfr mutation and high pdl1 - what is the role of immunotherapy in tre
-
1:17:52
egfr initial treatment, acquired resistance and q&a with h. jack west, md and helena yu, md
-
1:26
first line treatment of egfr mutation-positive nsclc
-
5:52
case based panel discussion - egfr - exon 20 mutation, treatment, targeted therapy, clinical trials
-
5:18
case based panel discussion - egfr mutation -the recommended treatment for common egfr mutations
-
3:07
third generation egfr tkis for acquired resistance